Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Neurokinin 1 Receptor Antagonist: a Novel Analgesic for Pain following Corneal Alkali Burn

Hideaki Someya; Amirreza Naderi; Aytan Musayeva; Shudan Wang; Francesca Kahale; Akitomo Narimatsu; Yihe Chen; Reza Dana

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):718.

ARVO Annual Meeting Abstract June 2023

NK1R Inhibition: a Novel Ocular Pain Management Strategy Following Mechanical Corneal Injury

Pier Luigi Surico; Amirreza Naderi; hideaki Someyaka; Aytan Musayeva; Francesca Kahale; Yihe Chen; Reza Dana

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):967.

ARVO Annual Meeting Abstract June 2022

Experimental autoimmune uveoretinitis inhibited by regulatory T cells augmented in type 1 diabetic mice.

Yoshiaki Nishio; Hideaki Someya; Kozo Harimoto; Tomohito Sato; Masataka Ito; Masaru Takeuchi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2223 – A0519.

ARVO Annual Meeting Abstract June 2022

Expression patterns of systemic factors and vitreous fluid cytokines by cluster analysis in PDR

Tomohito Sato; Rina Okazawa; Hideaki Someya; Toshio Enoki; Masataka Ito; Masaru Takeuchi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2198 – F0261.

ARVO Annual Meeting Abstract July 2019

Risk and Prognostic Factors of Neovascular Glaucoma After 25-gage Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study

Kei Takayama; Hideaki Someya; Hiroshi Yokoyama; Yoshihiro Takamura; Masakazu Morioka; Seiji Sameshima; Tetsuo Ueda; Shigehiko Kitano; Maki Tashiro; Masahiko Sugimoto; Mineo Kondo; Taiji Sakamoto; Masaru Takeuchi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6562.

ARVO Annual Meeting Abstract July 2018

The utility to evaluate inflammatory cytokines in the aqueous humor and aqueous flare in patients with proliferative diabetic retinopathy.

Yuki Fujita; Tomohito Sato; Hideaki Someya; Kei Takayama; Yoko Karasawa; Masaru Takeuchi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5373.

ARVO Annual Meeting Abstract June 2017

Comparison of efficacy of vitrectomy and internal limiting membrane peeling for maculopathy involved in proliferative diabetic retinopathy

Hideaki Someya; Yoshihiro Takamura; Masakazu Morioka; Hiroshi Yokoyama; Takeshi Kimura; Seiji Sameshima; Taiji Sakamoto; Masaru Takeuchi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2145.

ARVO Annual Meeting Abstract June 2017

Two years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study dataTwo years outcomes in eyes receiving aflibercept according to fixed 2 month interval for neovascular age-related macular degeneration: observational study data

Koji Kanda; Tomohito Sato; Manzo Taguchi; Hideaki Someya; Toshihiko Murata; Masaru Takeuchi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2164.

ARVO Annual Meeting Abstract September 2016

Correlations between intraocular pressure, duration of acute glaucoma and levels of cytokines in aqueous humor in patients with first acute glaucoma attack

Tomohito Sato; Masaru Takeuchi; Yoko Karasawa; Haruna Shimazaki; Shinpei Sugaoka; Hideaki Someya; Manzou Taguchi; Takayuki Kanda; Masataka Ito; Toshio Enoki

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5620.

Advertisement